MAPT and Alzheimer disease: The levels and the activity of the candidate biomarkers and the concentration of the core AD biomarkers are reported in Supplementary Table 2, while the patterns of the core CSF AD biomarkers Aβ42/40 ratio, p-tau, and t-tau, used for AT(N) classification, are reported in Supplementary Fig. 2.